AZoLifeSciences on MSN
Bispecific antibodies for SARS-CoV-2 variant neutralization
It has been five years since the onset of the coronavirus disease 2019 (COVID-19) pandemic. Many monoclonal antibody ...
Antibody drugs such as monoclonal antibodies (mAb), bispecific antibodies, antibody-drug conjugates (ADCs), and nanobodies garnered increased interest in research and development circles. Sino ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results